Aimovig

Aimovig (Erenumab) is a subcutaneous injection used for migraine prevention. This medication is designed to reduce the frequency of migraine episodes in eligible patients.

Aimovig is primarily used for the prevention of migraines. It is not intended for the acute treatment of migraines but rather to reduce their occurrence over time. Patients may wonder, 'what is Aimovig used for?' and the answer is that it is specifically formulated to help manage and prevent migraine headaches.

Common effects of Aimovig may include injection site reactions such as pain, redness, or swelling. Some users might experience constipation, muscle tightness, or fatigue. These effects are generally mild and temporary.

Aimovig should be used with caution in patients with a history of hypersensitivity to Erenumab or any of its components. It is important to follow the prescribed administration guidelines and consult a healthcare provider before use.

Aimovig may interact with other medications, particularly those that affect the cardiovascular system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.